Page last updated: 2024-09-03

reboxetine and Atrophy, Muscular, Peroneal

reboxetine has been researched along with Atrophy, Muscular, Peroneal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baghai, TC; Laenger, A; Leicht, G; Lindhaus, S; Rupprecht, R; Schule, C	1

Other Studies

1 other study(ies) available for reboxetine and Atrophy, Muscular, Peroneal

Article	Year
Electroconvulsive therapy in a patient with concomitant depression and charcot-marie-tooth disease. The American journal of psychiatry, 2008, Volume: 165, Issue:6 Topics: Aged; Charcot-Marie-Tooth Disease; Combined Modality Therapy; Comorbidity; Contraindications; Depressive Disorder, Major; Electroconvulsive Therapy; Humans; Male; Morpholines; Personality Inventory; Reboxetine; Risperidone; Treatment Outcome	2008

Article

Year

Electroconvulsive therapy in a patient with concomitant depression and charcot-marie-tooth disease.

The American journal of psychiatry, 2008, Volume: 165, Issue:6

Topics: Aged; Charcot-Marie-Tooth Disease; Combined Modality Therapy; Comorbidity; Contraindications; Depressive Disorder, Major; Electroconvulsive Therapy; Humans; Male; Morpholines; Personality Inventory; Reboxetine; Risperidone; Treatment Outcome

2008